WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark IndiMag was filed as Word mark on 01/24/2019 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1472576 |
| Countries | 
|
| Base trademark |
No. 017934152,
July 24, 2018
|
| Application date | January 24, 2019 |
| Expiration date | January 24, 2029 |
Trademark owner
Deutscher Platz 5b
04103 Leipzig
DE
04103 Leipzig
DE
Trademark representatives
Fasanenstr. 29
10719 Berlin
DE
goods and services
01
Chemical, biochemical and biotechnological products for
industrial and scientific purposes and laboratory analysis,
reagents and solvents for sample preparation, modification
and manipulation of cells as well as for labelling,
separation, isolation, purification, amplification and/or
analysis of natural or synthetic biopolymers, namely nucleic
acids, oligonucleotides, proteins, macromolecules and
biologically active substances; chemicals or biochemical
products used in industry, in particular substances for
molecular biological, biochemical and immunological testing
and analysis; kits comprising chemical products for sample
preparation, modification and manipulation of samples and
cells as well as for labelling, separation, isolation,
purification, amplification and/or analysis of natural or
synthetic biopolymers, namely nucleic acids,
oligonucleotides, proteins, macromolecules and biologically
active substances, namely nucleic acids from biological or
biochemical sample material, included in this class
05
Pharmaceutical and veterinary medical products as well as
products for healthcare purposes, diagnostic preparations
for medical and veterinary purposes; diagnostic agents for
medical, veterinary, laboratory medical and forensic
purposes, including agents for in-vitro diagnostics;
diagnostic agents for medical and veterinary purposes,
namely biological and preparations for testing diseases in
cattle, pigs, and other animals; diagnostic preparations for
medical and veterinary purposes; reagents, oligonucleotides,
antibodies, in-vitro diagnostics and control reagents for
medical purposes, being kit components; testing equipment
for sale in kit form, for medical, veterinary, dental, legal
medical, laboratory medical and forensic purposes; products
for medical and veterinary medical purposes, namely
diagnostic preparations, namely for sample preparation,
modification and manipulation of cells as well as for
labelling, separation, isolation, purification,
amplification and/or analysis of natural or synthetic
biopolymers, namely nucleic acids, oligonucleotides,
proteins, macromolecules and biologically active substances;
chemical, biochemical and biotechnological products, namely
reagents and solvents for sample preparation, modification
and manipulation of cells; in vitro diagnostic preparations
for medical purposes; kits comprising products for medical
and veterinary medical diagnostic purposes (terms considered
too vague in the opinion of the International Bureau – Rule
13 (2) (b) of the Common Regulations); kits, containing
reagents, oligonucleotides, antibodies, in-vitro diagnostic
preparations, control reagents for medical or veterinary
use; test strips for medical use
09
Molecular biological and immunological test systems (terms
considered too vague in the opinion of the International
Bureau – Rule 13 (2) (b) of the Common Regulations), kits
for multiplex PCR tests containing at least of the following
components, devices for removing, marking, applying and
identifying biological or biochemical samples, sequencing
apparatus, PCR cyclers, including associated hardware and
software (terms considered too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Common
Regulations); scientific apparatus and instruments;
apparatus and instruments for scientific research in
laboratories; molecular biological and immunological testing
systems (terms considered too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Common
Regulations), kits for multiplex PCR tests, including
hardware and software therefor; electronic or online manuals
and/or instruments for biochemical, molecular biological and
immunological testing sold in a kit
10
Surgical, medical, dental and veterinary apparatus and
instruments; medical apparatus, instruments and articles;
samples and apparatus for testing and analyzing biological
material (terms considered too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Common
Regulations)
42
Molecular biological, biochemical and immunological
analysis; conducting molecular biological, biochemical and
immunological analysis for testing diseases in cattle, pigs
and other animals; scientific and technological services and
research; scientific research for medical purposes; services
for screening personal samples for antibodies or antigens
(terms considered too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Common
Regulations); services for detecting or measuring selected
antibodies or antigens in personal samples; laboratory
services relating to the production of monoclonal or
polyclonal antibodies; medical scientific research,
including biological research and especially research into
human monoclonal antibodies and development of
pharmaceutical products based on human monoclonal
antibodies
44
Information services relating to veterinary pharmaceuticals;
providing information relating to veterinary services;
veterinary services (professional consultancy relating to
-); laboratory analysis services relating to the treatment
of animals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 4, 2022 | 2022/1 Gaz | US | Rejection |
| August 19, 2021 | 2021/34 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 15, 2021 | 2021/16 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 3, 2021 | 2021/7 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 17, 2021 | 2021/4 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 25, 2020 | 2020/40 Gaz | KR | Rejection |
| August 13, 2020 | 2020/34 Gaz | JP | Rejection |
| July 30, 2020 | 2020/40 Gaz | EM | RAW: Partial Ceasing Effect |
| June 3, 2020 | 2020/24 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 22, 2020 | 2020/23 Gaz | CH | Rejection |
| March 12, 2020 | 2020/11 Gaz | KR | Rejection |
| December 2, 2019 | 2019/49 Gaz | IN | Rejection |
| October 17, 2019 | 2019/43 Gaz | AU | Rejection |
| September 7, 2019 | 2019/37 Gaz | SG | Rejection |
| August 26, 2019 | 2019/35 Gaz | CN | Rejection |
| July 19, 2019 | 2019/30 Gaz | US | Rejection |
| January 24, 2019 | 2019/23 Gaz | EM | Registration |
ID: 141472576